Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. ImmuCell
ICCC

Buy ImmuCell (ICCC) Stock

ICCC
See ICCC stock price and Buy/Sell ImmuCell with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
ICCC

ImmuCell (ICCC)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About ImmuCell (ICCC)

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
Market Cap
$63.57M
1 Year High
$10.96
Volume
2.17k
1 Year Low
$7.30
Price to Earnings Ratio
237.28
Open
$7.85
Dividend Rate
High
$8.21
Dividend Yield
Low
$7.85

Community

People who own or watch ICCC stock

ImmuCell Stock News

ImmuCell stock rating

What analysts recommend for ICCC stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1

ImmuCell price target

What analysts think ICCC will be worth
Low $7.30
High $14
Current $7.99
Target $14

Events

List of events that could affect ICCC stock.
11Aug

Earnings data Q2 2022

14Nov

Earnings data Q3 2022

ImmuCell earnings

The value each share was expected to gain vs. the value that each share actually gained
0.03
-0
-0.03
-0.06
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021

Expected EPS
Q4 2021
-$0.01
Actual EPS
Q4 2021
$0.01

Buy ImmuCell (ICCC) Stock

ICCC
See ICCC stock price and Buy/Sell ImmuCell with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch ICCC stock
  • kellyh58 avatar
  • sapphireisle avatar
  • KimoneCalder avatar
  • IM4DmonE avatar
  • ngostevskyh avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.